Aegle Therapeutics
0 followers
Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ("DEB"), a rare genetic pediatric connective tissue disorde... Read more
Org chart
Shelley A. Hartman
Collapse
Heidi Kempinski
Chief Operational Officer
Evangelos V. Badiavas
Inventor, Founder & Chief Scientific Officer
Willistine Lenon
VP, Clinical Operations
